Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Verstraete

Showing results (111-120 of 414) with videos related to

Pageof 42
Sort By:
La Presse Medicale|April 10, 1971
[Administrative and clinical appreciation of new drugs]M Verstraete
Minerva Medica|March 24, 1973
[Problems of new drugs in Europe. Introduction]M Verstraete
Drugs|January 1, 1973
The present status of thrombolytic agentsM Verstraete
Drugs|February 1, 1989
Thrombolysis. An approach still on the moveM Verstraete
La Revue Du Praticien|December 11, 1977
[Indications and uncertainties of antiaggregating agents]M Verstraete
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Molecular biology of human plasminogen. II. Metabolism in physiological and some pathological conditions in manD Collen, M Verstraete
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1982
[Prostaglandins, thrombosis and hemorrhage]M Verstraete, J Vermylen
Drugs & Aging|January 1, 1996
Optimising thrombolytic therapy in elderly patients with acute myocardial infarctionM Verstraete, D Collen
Nouvelle Revue Francaise D'Hematologie|January 1, 1985
[Tissue plasminogen activator: a new thrombolytic specific t fibrin]M Verstraete, D Collen
Circulation|April 1, 1994
Key references on thrombolytic therapy 1983-1993D Collen, M Verstraete
Pageof 42

Showing results (111-120 of 414) with videos related to

Sort By:
Pageof 42
La Presse Medicale|April 10, 1971
[Administrative and clinical appreciation of new drugs]M Verstraete
Minerva Medica|March 24, 1973
[Problems of new drugs in Europe. Introduction]M Verstraete
Drugs|January 1, 1973
The present status of thrombolytic agentsM Verstraete
Drugs|February 1, 1989
Thrombolysis. An approach still on the moveM Verstraete
La Revue Du Praticien|December 11, 1977
[Indications and uncertainties of antiaggregating agents]M Verstraete
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Molecular biology of human plasminogen. II. Metabolism in physiological and some pathological conditions in manD Collen, M Verstraete
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1982
[Prostaglandins, thrombosis and hemorrhage]M Verstraete, J Vermylen
Drugs & Aging|January 1, 1996
Optimising thrombolytic therapy in elderly patients with acute myocardial infarctionM Verstraete, D Collen
Nouvelle Revue Francaise D'Hematologie|January 1, 1985
[Tissue plasminogen activator: a new thrombolytic specific t fibrin]M Verstraete, D Collen
Circulation|April 1, 1994
Key references on thrombolytic therapy 1983-1993D Collen, M Verstraete
Pageof 42